# Urinary Track Infection Prevention After Urogynecological Surgery

> **NCT03818321** · PHASE2 · COMPLETED · sponsor: **TriHealth Inc.** · enrollment: 185 (actual)

## Conditions studied

- Urinary Tract Infections
- Urinary Retention Postoperative
- Pelvic Organ Prolapse

## Interventions

- **DRUG:** Methenamine Hippurate 1 g tablet
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT03818321
- **Lead sponsor:** TriHealth Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-17
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2022-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03818321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03818321, "Urinary Track Infection Prevention After Urogynecological Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03818321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*